Table of Contents Author Guidelines Submit a Manuscript
Child Development Research
Volume 2014, Article ID 358608, 6 pages
http://dx.doi.org/10.1155/2014/358608
Review Article

Terbutaline and Associated Risks for Neurodevelopmental Disorders

1TIRR Memorial Hermann, Houston, TX, USA
2Neurobehavioral Associates, LLC., Augusta, GA, USA

Received 25 May 2014; Accepted 26 June 2014; Published 15 July 2014

Academic Editor: Nobuo Masataka

Copyright © 2014 Robert Perna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Gaudet, K. Singh, L. Weeks, B. Skidmore, A. Tsertsvadze, and M. T. Ansari, “Effectiveness of terbutaline pump for the prevention of preterm birth: a systematic review and meta-analysis,” PLoS ONE, vol. 7, no. 2, Article ID e31679, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Rhodes, F. J. Seidler, A. Abdel-Rahman et al., “Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex,” Journal of Pharmacology and Experimental Therapeutics, vol. 308, no. 2, pp. 529–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. MacDonald, L. R. Blackmon, D. G. Batton et al., “Perinatal care at the threshold of viability,” Pediatrics, vol. 110, no. 5, pp. 1024–1027, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Aschenbrenner, “Warning against using terbutaline to prevent preterm labor,” The American Journal of Nursing, vol. 111, no. 6, p. 24, 2011. View at Google Scholar
  5. R. L. Goldenberg, “The management of preterm labor,” Obstetrics & Gynecology, vol. 100, no. 5, pp. 1020–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Luciana, L. Lindeke, M. Georgieff, M. Mills, and C. A. Nelson, “Neurobehavioral evidence for working-memory deficits in school-aged children with histories of prematurity,” Developmental Medicine & Child Neurology, vol. 41, no. 8, pp. 521–533, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Nakhat, A. Kondawar, I. Babla, L. Rathi, and P. Yeole, “Studies on buccoadhesive tablets of terbutaline sulphate,” Indian Journal of Pharmaceutical Sciences, vol. 69, no. 4, pp. 505–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Kaae, L. Agertoft, S. Pedersen et al., “Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline,” British Journal of Clinical Pharmacology, vol. 58, no. 4, pp. 411–418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Pitzer, M. H. Schmidt, G. Esser, and M. Laucht, “Child development after maternal tocolysis with beta-sympathomimetic drugs,” Child Psychiatry & Human Development, vol. 31, no. 3, pp. 165–182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Sanchez-Ramos, A. M. Kaunitz, F. L. Gaudier, and I. Delke, “Efficacy of maintenance therapy after acute tocolysis: a meta-analysis,” The American Journal of Obstetrics and Gynecology, vol. 181, no. 2, pp. 484–490, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. ACOG Committee on Practice Bulletins—Obstetrics, “ACOG practice bulletin. Management of preterm labor. Number 43, May 2003,” International Journal of Gynecology and Obstetrics, vol. 82, no. 1, pp. 127–135, 2008. View at Google Scholar
  12. M. H. Beall, B. W. Edgar, R. H. Paul, and T. Smith-Wallace, “A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor,” American Journal of Obstetrics and Gynecology, vol. 153, no. 8, pp. 854–859, 1985. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. Nightingale, “Warning on use of terbutaline sulfate for preterm labor,” The Journal of the American Medical Association, vol. 279, no. 1, p. 9, 1998. View at Publisher · View at Google Scholar
  14. M. Hadders-Algra, B. C. L. Touwen, and H. J. Huisjes, “Long-term follow-up of children prenatally exposed to ritodrine,” British Journal of Obstetrics and Gynaecology, vol. 93, no. 2, pp. 156–161, 1986. View at Publisher · View at Google Scholar · View at Scopus
  15. F. R. Witter, A. W. Zimmerman, J. P. Reichmann, and S. L. Connors, “In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes,” The American Journal of Obstetrics and Gynecology, vol. 201, no. 6, pp. 553–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Klimek, G. Rajkowska, S. N. Luker et al., “Brain noradrenergic receptors in major depression and schizophrenia,” Neuropsychopharmacology, vol. 21, no. 1, pp. 69–81, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. Garofolo, F. J. Seidler, M. M. Cousins, C. A. Tate, D. Qiao, and T. A. Slotkin, “Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver,” Brain Research Bulletin, vol. 59, no. 4, pp. 319–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. L. Kreider, F. J. Seidler, and T. A. Slotkin, “β-Adrenoceptor modulation of transiently overexpressed α 2-adrenoceptors in brain and peripheral tissues: cellular mechanisms underlying the developmental toxicity of terbutaline,” Brain Research Bulletin, vol. 62, no. 4, pp. 305–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. A. Slotkin and F. J. Seidler, “Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats,” Brain Research Bulletin, vol. 73, no. 4–6, pp. 301–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. A. Croen, S. L. Connors, M. Matevia, Y. Qian, C. Newschaffer, and A. W. Zimmerman, “Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders,” Journal of Neurodevelopmental Disorders, vol. 3, no. 4, pp. 307–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Connors, D. E. Crowell, C. G. Eberhart et al., “β2-Adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins,” Journal of Child Neurology, vol. 20, no. 11, pp. 876–884, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. The Food and Drug Administration, “Warning on use of terbutaline sulfate for preterm labor,” Journal of American Medical Association, vol. 279, no. 1, article 9, 1998. View at Google Scholar
  23. N. S. Fox, S. E. Gelber, R. B. Kalish, and S. T. Chasen, “Contemporary practice patterns and beliefs regarding tocolysis among U.S. maternal-fetal medicine specialists,” Obstetrics and Gynecology, vol. 112, no. 1, pp. 42–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Morgan, R. L. Goldenberg, and J. Schulkin, “Obstetrician-gynecologists' screening and management of preterm birth,” Obstetrics and Gynecology, vol. 112, no. 1, pp. 35–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Chawanpaiboon, M. Laopaiboon, P. Lumbiganon, U. S. Sangkomkamhang, and T. Dowswell, “Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes,” The Cochrane Database of Systematic Reviews, vol. 3, Article ID CD010800, 2014. View at Publisher · View at Google Scholar
  26. C. R. Reynolds and R. W. Kamphaus, Behavior Assessment System for Children, American Guidance Service, Circle Pines, Minn, USA, 1992.
  27. D. Wechsler, Wechsler Intelligence Scale for Children, The Psychological Corporation, San Antonio, Tex, USA, 4th edition, 2003.
  28. D. C. Delis, J. H. Kramer, E. Kaplan, B. A. Ober, and L. J. Fridlund, California Verbal Learning Test-Childrens Version, Psychological Corporation, San Antonio, Tex, USA, 1994.
  29. B. Cohen, Childrens Memory Scale, The Psychological Corporation, San Antonio, Tex, USA, 1997.
  30. D. C. Delis, E. Kaplan, and J. H. Kramer, The Delis-Kaplan Executive Function System, The Psychological Corporation, San Antonio, Tex, USA, 2001.
  31. D. Wechsler, Wechsler Individual Achievement Test (WIAT-III), Pearson, San Antonio, Tex, USA, 3rd edition, 2009.
  32. J. E. Meyers and K. R. Meyers, Rey Complex Figure Test and Recognition Trial, Psychological Assessment Resources, Odessa, Fla, USA, 1995.
  33. R. K. Heaton, G. J. Chelune, J. L. Talley, G. Kay, and G. Curtiss, Wisconsin Card Sorting Test Manual: Revised and Expanded, Psychological Assessment, Odessa, Fla, USA, 1993.
  34. C. K. Conners, J. N. Epstein, A. Angold, and J. Klaric, “Continuous performance test performance in a normative epidemiological sample,” Journal of Abnormal Child Psychology, vol. 31, no. 5, pp. 555–562, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. T. N. Tombaugh, TOMM, Test of Memory Malingering, Multi-Health Systems, New York, NY, USA, 1996.
  36. D. Wechsler, Wechsler Memory Scale-III (WMS-III), Pearson Assessments, San Antonio, Tex, USA, 1999.
  37. G. S. Wilkinson and G. J. Robertson, Wide Range Achievement Test 4 (WRAT4), PAR, Lutz, Fla, USA, 2006.
  38. A. T. Beck, R. A. Steer, and G. K. Brown, Manual for the Beck Depression Inventory—II, Psychological Corporation, San Antonio, Tex, USA, 1996.
  39. A. T. Beck and R. A. Steer, Beck Anxiety Inventory Manual, Psychological Corporation, San Antonio, Tex, USA, 1993.